Cargando…

E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway

BACKGROUND: Recent studies have indicated that some members of the tripartite motif (TRIM) proteins function as important regulators for non-small cell lung cancer (NSCLC), However, the regulatory mechanism underpinning aberrant expression of TRIM in NSCLC remains unclear. Here we report that TRIM15...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Manman, Wang, Lijing, Sun, Zhengui, Chen, Xingwu, Wang, Hanli, Qin, Lilong, Zhao, Wenying, Geng, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082862/
https://www.ncbi.nlm.nih.gov/pubmed/35534896
http://dx.doi.org/10.1186/s12964-022-00875-7
_version_ 1784703295869157376
author Liang, Manman
Wang, Lijing
Sun, Zhengui
Chen, Xingwu
Wang, Hanli
Qin, Lilong
Zhao, Wenying
Geng, Biao
author_facet Liang, Manman
Wang, Lijing
Sun, Zhengui
Chen, Xingwu
Wang, Hanli
Qin, Lilong
Zhao, Wenying
Geng, Biao
author_sort Liang, Manman
collection PubMed
description BACKGROUND: Recent studies have indicated that some members of the tripartite motif (TRIM) proteins function as important regulators for non-small cell lung cancer (NSCLC), However, the regulatory mechanism underpinning aberrant expression of TRIM in NSCLC remains unclear. Here we report that TRIM15 plays important roles in NSCLC progression through modulating Keap1-Nrf2 signaling pathway. METHODS: TRIM15 expression was evaluated by western blot analysis, tissue microarray-based immunohistochemistry analysis. The interactions between TRIM15 and Keap1 were analyzed by co-immunoprecipitation (Co-IP) and immunofluorescence co-localization assay. The correlation between TRIM15 and Keap1 was measured by Co-IP and ubiquitination analysis in vitro. Gain- and lost-of-function experiments were used to detect TRIM15 promotes proliferation and invasion of NSCLC cells both in vitro and vivo. RESULTS: Here, we revealed that TRIM15 was frequently upregulated in NSCLC samples and associated with poor prognosis. Functionally, TRIM15 knockdown resulted in decreased cancer cell proliferation and metastasis, whereas ectopic TRIM15 expression facilitated tumor cancer cell proliferation and metastasis in vitro and in vivo. Moreover, TRIM15 promoted cell proliferation and metastasis depends on its E3 ubiquitin ligase. Mechanistically, TRIM15 directly targeted Keap1 by ubiquitination and degradation, the principal regulator of Nrf2 degradation, leading to Nrf2 escaping from Keap1-mediated degradation, subsequently promoting antioxidant response and tumor progression. CONCLUSIONS: Therefore, our study characterizes the pivotal roles of TRIM15 promotes NSCLC progression via Nrf2 stability mediated by promoting Keap1 ubiquitination and degradation and could be a valuable prognostic biomarker and a potential therapeutic target in NSCLC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-022-00875-7.
format Online
Article
Text
id pubmed-9082862
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90828622022-05-10 E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway Liang, Manman Wang, Lijing Sun, Zhengui Chen, Xingwu Wang, Hanli Qin, Lilong Zhao, Wenying Geng, Biao Cell Commun Signal Research BACKGROUND: Recent studies have indicated that some members of the tripartite motif (TRIM) proteins function as important regulators for non-small cell lung cancer (NSCLC), However, the regulatory mechanism underpinning aberrant expression of TRIM in NSCLC remains unclear. Here we report that TRIM15 plays important roles in NSCLC progression through modulating Keap1-Nrf2 signaling pathway. METHODS: TRIM15 expression was evaluated by western blot analysis, tissue microarray-based immunohistochemistry analysis. The interactions between TRIM15 and Keap1 were analyzed by co-immunoprecipitation (Co-IP) and immunofluorescence co-localization assay. The correlation between TRIM15 and Keap1 was measured by Co-IP and ubiquitination analysis in vitro. Gain- and lost-of-function experiments were used to detect TRIM15 promotes proliferation and invasion of NSCLC cells both in vitro and vivo. RESULTS: Here, we revealed that TRIM15 was frequently upregulated in NSCLC samples and associated with poor prognosis. Functionally, TRIM15 knockdown resulted in decreased cancer cell proliferation and metastasis, whereas ectopic TRIM15 expression facilitated tumor cancer cell proliferation and metastasis in vitro and in vivo. Moreover, TRIM15 promoted cell proliferation and metastasis depends on its E3 ubiquitin ligase. Mechanistically, TRIM15 directly targeted Keap1 by ubiquitination and degradation, the principal regulator of Nrf2 degradation, leading to Nrf2 escaping from Keap1-mediated degradation, subsequently promoting antioxidant response and tumor progression. CONCLUSIONS: Therefore, our study characterizes the pivotal roles of TRIM15 promotes NSCLC progression via Nrf2 stability mediated by promoting Keap1 ubiquitination and degradation and could be a valuable prognostic biomarker and a potential therapeutic target in NSCLC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-022-00875-7. BioMed Central 2022-05-09 /pmc/articles/PMC9082862/ /pubmed/35534896 http://dx.doi.org/10.1186/s12964-022-00875-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liang, Manman
Wang, Lijing
Sun, Zhengui
Chen, Xingwu
Wang, Hanli
Qin, Lilong
Zhao, Wenying
Geng, Biao
E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway
title E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway
title_full E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway
title_fullStr E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway
title_full_unstemmed E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway
title_short E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway
title_sort e3 ligase trim15 facilitates non-small cell lung cancer progression through mediating keap1-nrf2 signaling pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082862/
https://www.ncbi.nlm.nih.gov/pubmed/35534896
http://dx.doi.org/10.1186/s12964-022-00875-7
work_keys_str_mv AT liangmanman e3ligasetrim15facilitatesnonsmallcelllungcancerprogressionthroughmediatingkeap1nrf2signalingpathway
AT wanglijing e3ligasetrim15facilitatesnonsmallcelllungcancerprogressionthroughmediatingkeap1nrf2signalingpathway
AT sunzhengui e3ligasetrim15facilitatesnonsmallcelllungcancerprogressionthroughmediatingkeap1nrf2signalingpathway
AT chenxingwu e3ligasetrim15facilitatesnonsmallcelllungcancerprogressionthroughmediatingkeap1nrf2signalingpathway
AT wanghanli e3ligasetrim15facilitatesnonsmallcelllungcancerprogressionthroughmediatingkeap1nrf2signalingpathway
AT qinlilong e3ligasetrim15facilitatesnonsmallcelllungcancerprogressionthroughmediatingkeap1nrf2signalingpathway
AT zhaowenying e3ligasetrim15facilitatesnonsmallcelllungcancerprogressionthroughmediatingkeap1nrf2signalingpathway
AT gengbiao e3ligasetrim15facilitatesnonsmallcelllungcancerprogressionthroughmediatingkeap1nrf2signalingpathway